| Bid Price | 1.10p | High Price | 1.31p |
|---|
| Ask Price | 1.20p | Low Price | 1.10p |
|---|
| Open Price | 1.32p | Spread | 8.33% |
|---|
| Prev Close | 1.32p | Volume | 1,735,828 |
|---|
Shield Therapeutics PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Apr 24, 2024 | 1.43 | 1.45 | 1.30 | 1.32 | 2,958,047 |
| Apr 23, 2024 | 1.43 | 1.43 | 1.40 | 1.43 | 700,061 |
| Apr 22, 2024 | 1.48 | 1.50 | 1.41 | 1.43 | 705,760 |
| Apr 19, 2024 | 1.48 | 1.50 | 1.42 | 1.48 | 1,069,534 |
| Apr 18, 2024 | 1.48 | 1.49 | 1.45 | 1.48 | 486,264 |
Shield Therapeutics PLC Information
| Name | Shield Therapeutics PLC | Index | FTSE AIM All Share |
|---|
| ISIN | GB00BYV81293 | Epic | STX |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | ASQ1 |
|---|
| Industry | Drug Manufacturers - Specialty & Generic | Sector | Healthcare |
|---|
| EMS | 15,000 | Trading Status | Regular Trading |
|---|
| Shares in Issue | 782.06 m | Prev Close | 1.32p |
|---|
| PE Ratio | 32.154341 | Market Cap | £8.61 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | -£0.02 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -0.558623 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 2.945937 | Quick Ratio | 2.579684 |
|---|
Shield Therapeutics PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 27/11/23 | BUY | Hans Hasler | NED | 2,000,000 @ £0.06 | £122,000.00 |
| 09/01/23 | PLAC | Hans Hasler | NED | 3,000,000 @ £0.06 | £180,000.00 |
| 09/01/23 | PLAC | Gregory Madison | CEO | 1,359,434 @ £0.06 | £81,566.00 |
| 09/01/23 | PLAC | Christian Schweiger | NED | 4,486,133 @ £0.06 | £269,168.00 |
| 06/01/23 | PLAC | Maria Lacerca-Allen | NED | 271,886 @ £0.06 | £16,313.00 |
Shield Therapeutics PLC News
